Advertise here
Advertise here
Headlines

Four year medical degrees reduce diversity of medical students and care for disadvantaged groups

Evie A Hall, a senior house officer in general medicine at University Hospital Crosshouse in Kilmarnock, UK, agrees with Finn and colleagues that a four-year undergraduate medical degree may hinder accessibility for those from disadvantaged socioeconomic backgrounds. Hall argues that a shorter degree program would lead to more intense study hours, potentially deterring students who…

Read More

Radnet’s DeepHealth and HOPPR forge partnership to advance AI in healthcare

DeepHealth, a subsidiary of RadNet, Inc., partners with HOPPR to develop AI models for cancer detection. This collaboration focuses on creating a Medical-Grade Generalized Foundational Model and Fine-Tuned models for breast, prostate, and lung cancer. The partnership aims to accelerate the development of AI solutions in radiology and health informatics. By combining HOPPR’s infrastructure with…

Read More

Diet May Affect Gut Hormones Less Than Drugs, Surgery

Researchers found that short-term adoption of low-carbohydrate or low-fat diets does not significantly affect gut-derived appetite hormones compared to pharmacologic treatments or bariatric surgery. A study on 20 adults showed that postprandial concentrations of certain hormones were higher after low-carb meals and lower after low-fat meals. However, no significant correlations were found between hormone responses…

Read More

Eli Lilly Moves Closer to Bringing Diabetes Patients a Once-Weekly Insulin Alternative

Eli Lilly’s once-weekly insulin, efsitora alfa, has shown promising results in two pivotal studies, being comparable to once-daily insulin in treating type 2 diabetes. The fusion protein aims to provide more stable glucose levels over a week, with positive outcomes in reducing hemoglobin A1C levels. This development brings the experimental insulin closer to competing with…

Read More

Health Secretary Becerra Touts Extreme Heat Protections. Farmworkers Want More.

US Health and Human Services Secretary Xavier Becerra visited Clarksburg, California, to discuss the Biden administration’s efforts to protect farmworkers from extreme heat and wildfire smoke. Becerra emphasized the need for stronger protections for farmworkers, who are on the front lines of the climate crisis. He highlighted the impact of heat and smoke on farmworkers’…

Read More

Long-term upadacitinib superior to methotrexate for rheumatoid arthritis

A study published in Arthritis Research & Therapy found that patients with rheumatoid arthritis (RA) treated with upadacitinib over 5 years showed greater reductions in disease activity compared to methotrexate. The study also found that upadacitinib had a more favorable risk-benefit profile than methotrexate. The long-term extension of the phase 3 SELECT-EARLY trial included 775…

Read More

Protein NSD2 found to drive early prostate cancer development

Researchers at the University of Michigan Health Rogel Cancer Center have discovered that the protein NSD2 alters the function of the androgen receptor, leading to rapid cell division and growth that fuels prostate cancer development. This study, published in Nature Genetics, sheds light on how the androgen receptor, which typically regulates normal prostate development, is…

Read More

New study finds skincare products could expose children to harmful phthalates

A study on children’s skincare products and exposure to harmful phthalates revealed that certain products, like lotions and oils, were associated with higher levels of specific phthalates in urine. Phthalates can disrupt endocrine function and have negative effects on children’s health. The study found differences in exposure based on race, ethnicity, and gender. Children from…

Read More

The End of Daily Pills?

Researchers have developed two versions of an experimental monthly injectable semaglutide-loaded hydrogel that shows extended drug release and good tolerance in rats. The formulation aims to address patient adherence issues with current once-weekly or daily dosing regimens for type 2 diabetes or obesity. The hydrogel, injected under the skin, forms a gel disk or microgel…

Read More

Night Owls At Higher Risk Of Diabetes: Study

Researchers have found a link between being a night owl, or someone who prefers staying up late and waking up later, and an increased risk of developing type 2 diabetes. This risk is not solely due to unhealthy lifestyle habits, such as poor diet and smoking. Night owls also tend to have larger waistlines and…

Read More

Low-dose IL-2 promising in bullous pemphigoid treatment

A study found that low-dose interleukin-2 therapy showed positive results in treating bullous pemphigoid, with an early onset of response compared to corticosteroids alone. Patients treated with IL-2 had fewer days to disease control and a significant expansion of Treg cells in the first 2 weeks of treatment. The study included 20 patients in a…

Read More

‘We falsely medicalized a true normal variant’

The article highlights how race-based clinical algorithms in medicine can lead to misdiagnosis and unnecessary treatments for people of different races. It shares a personal story of a woman, Vanessa Apea, who was wrongly diagnosed with leukemia due to a low white blood cell count common in people of African or Middle Eastern ancestry. The…

Read More

Patients receiving steroids are more than twice as likely to develop diabetes, UK study finds

A study presented at the European Association for the Study of Diabetes found that patients treated with systemic glucocorticoids are over twice as likely to develop diabetes compared to those not receiving the treatment. Glucocorticoids are commonly used to treat inflammation and autoimmune conditions, causing adverse effects like increased blood sugar levels and diabetes. The…

Read More

Study shows increased alcohol consumption directly raises dementia risk

A recent study explored the association between alcohol consumption and dementia risk in current drinkers through linear and non-linear Mendelian randomization analysis. The findings challenge previous beliefs by suggesting that as predicted alcohol consumption increases based on genetic factors, so does the risk of developing dementia. While past studies have shown a potential protective effect…

Read More

Ivonescimab Tops Pembro in Advanced PD-L1-Positive NSCLC

The HARMONi-2 trial showed that ivonescimab improved progression-free survival compared to pembrolizumab in PD-L1-positive advanced NSCLC. This first phase 3 study with ivonescimab highlights its potential as a new standard of care. The trial involved 398 patients and found that ivonescimab doubled PFS to 11.1 months. Ivonescimab also had higher response rates and a manageable…

Read More

Here Are Top Choices For Your Immunity Needs

Immunity boosters like Echinacea are gaining popularity as people seek supplements to enhance their immune defenses. Echinacea is a flowering plant known for its immune-boosting properties and broader health benefits. It can reduce inflammation, improve skin health, enhance mood, and reduce the need for antibiotics by preventing respiratory infections. While generally safe, Echinacea may cause…

Read More

FDA clears Think Surgical robotic system for use with Medacta knee implants

Think Surgical Inc. has received FDA clearance for its robotic system to be used with Medacta knee systems. The collaboration agreement between Think Surgical and Medacta will combine the robotic surgery platform and knee systems for patients undergoing robotic-assisted total knee replacement. This partnership aligns with Medacta’s commitment to innovation and Think Surgical’s dedication to…

Read More

Air travel may affect insulin pump delivery in people with type 1 diabetes

Research has shown that altitude changes during commercial flights can impact the blood glucose levels of people with type 1 diabetes using insulin pump therapy. Insulin delivery from pumps was tested in a hypobaric chamber to mimic flight conditions, with results showing minor fluctuations in insulin over-delivery during ascent and under-delivery during descent. Rapid decompression…

Read More

Breakthrough technique enables clear visualization of organs in the body

Researchers at Stanford University have developed a new technique that makes overlying tissues transparent to visible light, allowing for better viewing of organs within the body. By using a food-safe dye called tartrazine, researchers were able to achieve transparency in animal subjects and believe it could have significant applications in medical diagnostics. The process involves…

Read More

Debate Over Best Treatment for High-Risk PE at ERS 2024

Treatment of acute, high-risk pulmonary embolism (PE) remains controversial among specialists. Systemic thrombolysis using rtPA is the current standard, but other mechanical and surgical options are emerging. Some believe rtPA is outdated due to technological advances, while others argue its efficacy and support its use. Alternatives like catheter-directed therapies and ECMO offer promise but also…

Read More

Makeup line designed to reduce eye irritation

At the Women in Ophthalmology Summer Symposium, Dr. Diane M. Hilal-Campo discusses Twenty/Twenty Beauty, an ophthalmologist-formulated eye makeup line designed to be easier on the eyes and prevent dry eye issues. The line includes products like mascara, which was in high demand from patients seeking a non-irritating option. This makeup line has received positive feedback…

Read More

Summit therapy beat Merck blockbuster Keytruda in late-stage lung cancer trial

Summit Therapeutics presented data at the World Conference on Lung Cancer showing that their experimental drug ivonescimab outperformed Merck’s Keytruda in a late-stage trial for lung cancer. The Phase 3 study, HARMONi-2, conducted by Akeso, enrolled nearly 400 patients with advanced non-small cell lung cancer. Ivonescimab reduced the risk of tumor progression by 49% compared…

Read More

HKUST researchers unveil eco-friendly disinfectant alternative to chloroxylenol

Researchers at HKUST have discovered a promising alternative to chloroxylenol, a commonly used disinfectant, called 2,6-DCQ. This alternative is more effective in combating bacteria, fungi, and viruses, and can be rapidly degraded in water environments. The study led by Prof. Zhang Xiangru found that 2,6-DCQ was significantly more effective than chloroxylenol in inactivating pathogens and…

Read More

Do Cannabis Users Need More Anesthesia During Surgery?

Older cannabis users undergoing surgery required higher doses of inhalational anesthetics compared to nonusers, according to a retrospective cohort study. The study included 22,476 patients aged 65 years or older, with 268 cannabis users matched to 1072 nonusers. Cannabis users had significantly higher average minimum alveolar concentrations of anesthesia than nonusers, though the clinical relevance…

Read More

Study Finds Women In 40s As Vulnerable As Men At 65

A recent study found that women in their 40s are as vulnerable to heat-related health risks as men at the age of 65. Previous research has shown that more women die from heat-related issues than men. The study from Penn State University found that middle-aged and older women are more physiologically vulnerable to high heat…

Read More

Rural Healthcare Goes Beyond Care: Targeting SDOH to Improve Health Outcomes

Social determinants of health (SDOH) have a significant impact on health outcomes, with poverty being strongly correlated with worse health and premature death. Rural Americans, especially racial minorities, face higher rates of poverty and limited access to healthcare services. Healthcare leaders are using SDOH data to build healthier communities. Transportation and affordability are key challenges…

Read More

Driving restrictions after ICD implantation may impede daily living

A study published in the European Heart Journal found that driving restrictions after implantable cardioverter defibrillator (ICD) implantation negatively impacted patient daily living and employment. Younger patients were more likely to report an impact. The study, which evaluated questionnaire responses from 2,741 patients in Denmark, found that driving restrictions affected the ability to maintain employment…

Read More

We’re reading about FDA inspections, Lilly insulin trial results

Amid the ongoing struggle of federal regulators to conduct drug manufacturing inspections post-COVID-19, concerns are raised about risks of contamination in drugs used by Americans. A significant number of pharmaceutical firms are overdue for safety inspections, posing potential quality issues. In other news, Eli Lilly’s once-weekly insulin is showing promise in pivotal studies, competing with…

Read More

Vitiligo: Combination Therapies and Emerging Treatments

According to Medscape Medical News, it may take up to a year to see significant results with topical immunosuppressants and narrowband ultraviolet B treatment. These treatments can be effective in managing certain conditions, but patients should be aware that they may not see immediate results. It is important to be patient and consistent with these…

Read More

Can AI Help Fix Our Demographic Time Bomb?

America is facing a demographic crisis with an aging population that is sicker and more expensive to care for. By 2030, there will not be enough healthcare workers to support the growing number of elderly individuals. Physician burnout is on the rise due to excessive workload and administrative tasks. AI has the potential to bridge…

Read More

Heron Therapeutics announces second-quarter financial results

Heron Therapeutics Inc. reported improved financial results in its second quarter of 2024, with $36 million in net product sales and $25.5 million in gross profit. The company’s CEO, Craig Collard, highlighted milestones and ongoing commercial success, emphasizing revenue growth, margin improvement, and expense reduction. Heron Therapeutics is expanding its partnership with CrossLink and progressing…

Read More

Ernest Kirwan | The BMJ

Ernest (Curly) Kirwan, born in Kolkata, India, to an Anglo-Irish ophthalmic surgeon father and American mother, spent his early years in India before moving to London in 1935. Evacuated to Portland, Oregon during the blitz in 1939, he returned to London in 1944 and later studied medicine at Gonville and Caius College. Patrick, Robert, Edward,…

Read More

Think you’re too busy for strength training at work? Try this quick and easy guide

Desk jobs can be harmful to health, but incorporating strength training into your workday can help. Starting with bodyweight exercises for the first two weeks, gradually progressing to using equipment like kettlebells or dumbbells. Over eight weeks, increase the difficulty by adding weight and increasing repetitions. The goal is progressive overload to continuously challenge your…

Read More

Advanced imaging techniques offer insights into brain microstructure and disease detection

Researchers compared nerve fiber orientations in a human brainstem using two imaging techniques: dMRI-based tractography and PS-OCT. Combining these methods could offer insights into brain microstructure and aid in early diagnosis of brain disorders. Isabella Aguilera-Cuenca from the University of Arizona presented the study at a conference. Understanding nerve fiber orientation is crucial for communication…

Read More

Colchicine Drug Interactions May Not Affect Safety, Efficacy

The presence of drug-drug interactions (DDIs) did not increase the risk for colchicine-related gastrointestinal adverse events or impact the effectiveness of colchicine in ambulatory patients with COVID-19, according to a study conducted by Lama S. Alfehaid, PharmD. A total of 4432 patients were given colchicine or a placebo, with a small percentage having potential DDIs….

Read More

Full FDA Approval of Travere’s Kidney Drug Stiffens Competition With Novartis, Calliditas

Travere Therapeutics drug Filspari received full FDA approval for treating the rare disease immunoglobulin A nephropathy (IgAN). The drug showed long-term benefits in slowing kidney function decline over two years. The approval removes a previous proteinuria threshold, expanding the eligible patient population to more than 70,000. Filspari is a small molecule that selectively blocks pathways…

Read More
Advertise here
error: Content is protected !!